Peter Jones
31 results.
GRAND RAPIDS, Mich. (Feb 20, 2018)—Van Andel Research Institute (VARI) Chief Scientific Officer Peter Jones, Ph.D., D.Sc., will be awarded an honorary doctorate from…
With the end of the year approaching, we asked the Institute’s leadership for a sneak peek into what they are most excited for in the…
With 2017 quickly coming to close, we’d like to reflect on all that’s been accomplished by rounding up some of this year’s most notable stories…
Studies to test whether epigenetic and immunotherapy combination therapies can extend survivorship in lung and bladder cancers GRAND RAPIDS, Mich. (Oct. 12, 2017)—Van Andel Research…
Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers By Dr. Peter Jones and Dr. Steve Baylin Co-leaders,…
VARI’s Chief Scientific Officer Peter Jones, Ph.D., D.Sc., has received a highly competitive 7-year, $7.8 million Outstanding Investigator Award grant from…
International collaboration pairs immunotherapy with an epigenetic drug to stop progression of chronic myelomonocytic leukemia and myelodysplastic syndrome into acute myeloid leukemia GRAND RAPIDS, Mich.…
GRAND RAPIDS, Mich. (May 31, 2017) – Peter Jones, Ph.D., D.Sc., chief scientific officer of Van Andel Research…